Doctor Erick

November 14, 2016

What Are the FDA’s New Compounded Drug Guidelines?

The FDA aims to protect the health of U.S citizens’ by assuring them safe and secure drugs as well as biologics. However, the […]
November 11, 2016

What Are The Phases Involved In A Clinical Trial?

Clinical trials are conducted for collecting data related to safety as well as the efficacy of new drug along with device development. There […]
November 7, 2016

How to Solve the Most Common Problems with Clinical Research?

Every year, millions of dollars are invested by pharmaceutical research and development companies due to clinical trial failures. All the capital invested on […]
November 1, 2016

What Are The Biggest Biosimilar Challenges?

The term biosimilar refers to a pharmaceutical drug that is similar to an originally approved biological product with significant differences in safety and […]
October 31, 2016

Centralized or On-Site Monitoring – Which is a Better Approach for Risk Based Monitoring?

In the nascent stage of Risk Based Monitoring, it started on-site. But, with the passage of time, the focus shifted towards centralized monitoring. […]
October 27, 2016

Difference between AE and SAE in a Clinical Trial!

Clinical trials can result in several complications related to the medical conditions of the participants involved in a clinical trial. During a clinical […]
October 24, 2016

Criteria That FDA Uses In Deciding To Approve A New Drug

There are different phases of developing a new drug. The first phase is a preclinical phase. The duration of this phase lasts for […]
October 21, 2016

Tips for Hiring Data Scientists

Data Science is a special field where talent matters much more than the availability of tools and techniques. Thus, it is extremely important […]
October 20, 2016

How Important is RBM for a CRA?

Drug development and clinical research are evolving. Researchers are making every effort to improve data safety and integrity. Thus regulators in the US […]